Study Finds Nearly 90% Increase in Advanced Breast Cancers in 33 Years

Phil Jensen

ADVERTISEMENT

breast cancerCoalition on Abortion/Breast Cancer
Press Release
Contact: Karen Malec, 847-421-4000
Date: March 4, 2013

The Coalition on Abortion/Breast Cancer commented on a study in the Journal of the American Medical Association published February 27, 2013. The authors, led by Rebecca Johnson, MD reported that the incidence of advanced breast cancer which, by the time of diagnosis, had already spread to distant locations (i.el bone, brain, lungs, etc.) among women aged 25-39 years had jumped by nearly 90% during a 33 year period. [1]

Noting there are more aggressive breast cancers and low survival rates among young women, researchers said the increases in the incidence of advanced cancers were statistically significant and climbed from 1.53% in 1976 to 2.90% in 2009. That’s an increase of 2.07% per year, compounded.

Rick Kriebel 2016

ADVERTISEMENT

“It’s utterly stunning that Johnson’s team called the increased incidence in advanced cancers among young women ‘small,’” charged Karen Malec, president of the Coalition on Abortion/Breast Cancer. “That’s a nearly doubled increase in the incidence of a disease with a mean five year fatality rate of 69%! By contrast, the mean five-year fatality rate among women with breast cancers that have not spread to distant sites is 13.2%.

“It’s peculiar, but not surprising, that the authors offered no hypotheses in their paper explaining the increased incidence in advanced cancers among young women,” argued Mrs. Malec. “Abortion and use of hormonal contraceptive steroids among teenagers are the elephants in the living room that the medical establishment ignores.” [2-5]

The rate of advanced breast cancer doubled for African Americans, ages 25-39, climbing from 3.14 in 1976 to 6.25 per 100,000 in 2009, with a statistically significant annual percent change of 3.50.

Woodrow Wilcox

ADVERTISEMENT

“Is this any wonder when the abortion rate for African American women is more than double that of white women?” asked Mrs. Malec.

By comparison, the rate of advanced breast cancer for non-Hispanic whites in the same age group climbed by 56% during that period from 1.52 in 1976 to 2.37 per 100,000 in 2009, with a statistically significant annual percent change of 2.67.

“Many more young women are at risk for developing advanced breast cancer in the future because of an ObamaCare mandate requiring employers to purchase insurance that will provide “free” (cancer-causing) hormonal contraceptive steroids and abortion-inducing drugs,” warned Malec. “It doesn’t matter to government officials how many lives are destroyed because of it.”

The Coalition on Abortion/Breast Cancer is an international women’s organization founded to protect the health and save the lives of women by educating and providing information on abortion as a risk factor for breast cancer.

References:

1. Johnson R, Chien F, Bleyer A. Incidence of breast cancer with distant involvement among women in the United States, 1976 to 2009. JAMA 2013;309(8):800-805.

2. Fifty-six of 71 epidemiologic studies, and biological and experimental evidence support the abortion-breast cancer link. List of epidemiologic studies available at: <http://www.bcpinstitute.org/FactSheets/BCPI-FactSheet-Epidemiol-studies.pdf>. See a discussion of epidemiological, biological and experimental evidence at: Lanfranchi, A. Normal breast physiology: The reasons hormonal contraceptives and induced abortion increase breast cancer risk. The Linacre Quarterly 2009;76:236-249. Available at:http://www.abortionbreastcancer.com/download/LQ_76_3_2_Lanfranchi.pdf

3. The World Health Organization lists estrogen-progestagen oral contraceptives (the birth control pill) in the highest level of carcinogenicity (as a cancer-causing agent) – Group 1. See IARC Monographs on the Evaluation of Carcinogenic Risks to Humans. Group 1, Carcinogenic to Humans. Available at: <http://monographs.iarc.fr/ENG/Classification/index.php>

4. Two studies strongly link use of the birth control pill with the deadly triple-negative breast cancer. Ma H, Wang Y, Sullivan-Halley J, Weiss L, Marchbanks PA, Spirtas R, Ursin G, Burkman RT, Simon MS, Malone KE, Strom BL, McDonald JA, Press MF, Bernstein L. Use of four biomarkers to evaluate the risk of breast cancer subtypes in the Women’s Contraceptive and Reproductive Experiences Study. Cancer Research 2010;70(2):575-587. Available at: <http://cancerres.aacrjournals.org/content/70/2/575.long>. Dolle J, Daling J, White E, Brinton L, Doody D, et al. Risk factors for triple-negative breast cancer in women under the age of 45 years.Cancer Epidemiol Biomarkers Prev 2009;18(4)1157-1166.

Available at: <http://www.abortionbreastcancer.com/download/Abortion_Breast_Cancer_Epid_Bio_Prev_2009.pdf>.

5. A 2006 review in the journal, Mayo Clinic Proceedings, reported a statistically significant 44% risk increase of premenopausal breast cancer among women who used the birth control pill before age 18. Kahlenborn C, Modugno F. Potter DM, Severs WB. Oral contraceptive use as a risk factor for premenopausal breast cancer: A meta-analysis. Mayo Clinic Proceedings 2006;81(10):1290-1302. Available at: <http://www.polycarp.org>.

Forgotten_Factor_Banner_Ad_653x197

ADVERTISEMENT


This article is printed with the permission of the author(s). Opinions expressed herein are the sole responsibility of the article’s author(s), or of the person(s) or organization(s) quoted therein, and do not necessarily represent those of American Clarion or Dakota Voice LLC.

Comment Rules: Please confine comments to salient ones that add to the topic; Profanity is not allowed and will be deleted; Spam, copied statements and other material not comprised of the reader’s own opinion will be deleted.


Similar Posts:

Newswire articles originate from a variety of sources including wire services, press releases and more. Newswire pieces are written by a representative of the person or organization that is the subject or source of the article and are presented as informational statements about the subject discussed.
Newswire
View all articles by Newswire
Print Friendly

Comments are closed.